Bloomberg News has obtained 18,000 emails from Jeffrey Epstein’s personal email account. The emails cover two decades and a wide range of topics, from the chilling to the mundane: Details of his Amazon purchases, his reaction to photos of young women, how he considered different potential plea deals.

Today on the show, Bloomberg’s Jason Leopold and Ava Benny-Morrison with host David Gura on the massive trove of emails — and what they tell us about Epstein, his powerful network, and his former girlfriend and associate Ghislaine Maxwell.

Read more: Epstein’s Inbox: A Trove of Emails Reveals Ghislaine Maxwell’s Secrets

Bloomberg News has obtained 18,000 emails from Jeffrey Epstein&rsquo;s personal email account. The emails cover two decades and a wide range of topics, from the chilling to the mundane: Details of his Amazon purchases, his reaction to photos of young women, how he considered different potential plea deals.
Today on the show, Bloomberg&rsquo;s Jason Leopold and Ava Benny-Morrison with host David Gura on the massive trove of emails &mdash; and what they tell us about Epstein, his powerful network, and his former girlfriend and associate Ghislaine Maxwell.
Read more:&nbsp;<a href="https://www.bloomberg.com/features/2025-jeffrey-epstein-emails-ghislaine-maxwell/?srnd=homepage-americas">Epstein&rsquo;s Inbox: A Trove of Emails Reveals Ghislaine Maxwell&rsquo;s Secrets</a>

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

Big Take

We Got 18,000 of Jeffrey Epstein’s Emails

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/8f9c62a1-ccac-4613-a7e6-b35500a31cd3/transcript

The trucking industry has long been dominated by older white men. But as those truckers steer toward retirement, who will replace them? 

On today’s Big Take podcast, host Sarah Holder hits the road with Bloomberg’s Jaewon Kang, who’s been exploring how one company is trying to transform its trucking workforce. And we hear from MIT’s Chris Caplice, DAT Freight and Analytics’ Dean Croke and two Walmart truckers about what’s working for the industry and the challenges it faces on the road ahead.

Read more: Walmart’s $115,000 Starting Pay and Better Rigs Draw Women to Trucking

Hosted by Sarah Holder Produced by Julia Press Reported by Jaewon Kang Edited by Tracey Samuelson Fact-checking by Rachael Lewis-Krisky Engineering by Katie McMurran

Senior Producer: Naomi Shavin Deputy Executive Producer: Julia Weaver Executive Producer: Nicole Beemsterboer

The trucking industry has long been dominated by older white men. But as those truckers steer toward retirement, who will replace them?&nbsp;
On today&rsquo;s Big Take podcast, host Sarah Holder hits the road with Bloomberg&rsquo;s Jaewon Kang, who&rsquo;s been exploring how one company is trying to transform its trucking workforce. And we hear from MIT&rsquo;s Chris Caplice, DAT Freight and Analytics&rsquo; Dean Croke and two Walmart truckers about what&rsquo;s working for the industry and the challenges it faces on the road ahead.
Read more: <a href="https://www.bloomberg.com/news/features/2025-12-18/us-trucking-shortage-spurs-walmart-to-raise-driver-truck-pay-to-115-000?srnd=undefined">Walmart&rsquo;s $115,000 Starting Pay and Better Rigs Draw Women to Trucking</a>
Hosted by Sarah Holder Produced by Julia Press Reported by Jaewon Kang Edited by Tracey Samuelson Fact-checking by Rachael Lewis-Krisky Engineering by Katie McMurran
Senior Producer: Naomi Shavin Deputy Executive Producer: Julia Weaver Executive Producer: Nicole Beemsterboer

Truckers Are Aging Out. Who Will Replace Them?

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a288c8d8-e3ab-4ff5-b961-b3b70145b13f/transcript

Treating cancer is a massive business. In 2024 alone, cancer treatments generated at least $200 billion in worldwide sales for the pharmaceutical industry, more than the obesity drug rush. But a Bloomberg News analysis showed that fewer than half of treatments reviewed — some of which have painful side effects — have been shown to extend patients’ lives.

On today’s Big Take podcast, Bloomberg senior healthcare reporter Robert Langreth takes host David Gura inside what some doctors call the “cancer-industrial complex” — from the regulatory landscape that ushered in a wave of lucrative new drugs to the damaging financial and health impacts some treatments can have on patients.

Read more:

Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives.

The Implants Were Supposed to Dissolve. They Didn’t.

Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work

Cancer Doctors Are Making a Fortune Off Drug-Trial Participants

One Generic Cancer Drug Costs $35. Or $134. Or $13,000.

Treating cancer is a massive business. In 2024 alone, cancer treatments generated at least $200 billion in worldwide sales for the pharmaceutical industry, more than the obesity drug rush. But a Bloomberg News analysis showed that fewer than half of treatments reviewed &mdash; some of which have painful side effects &mdash; have been shown to extend patients&rsquo; lives.
On today&rsquo;s Big Take podcast, Bloomberg senior healthcare reporter Robert Langreth takes host David Gura inside what some doctors call the &ldquo;cancer-industrial complex&rdquo; &mdash; from the regulatory landscape that ushered in a wave of lucrative new drugs to the damaging financial and health impacts some treatments can have on patients.
Read more:
<a href="https://www.bloomberg.com/graphics/2025-cancer-treatment-costs">Cancer Drugs Cost More Than Ever. They Often Don&rsquo;t Extend Lives.</a>
<a href="https://www.bloomberg.com/features/2025-biozorb-cancer-implant-recall">The Implants Were Supposed to Dissolve. They Didn&rsquo;t.</a>
<a href="https://www.bloomberg.com/features/2025-experimental-cheaper-treatments-cancer-capitalism">Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work</a>
<a href="https://www.bloomberg.com/features/2025-cancer-drug-trials-money/?sref=RTae6dyr">Cancer Doctors Are Making a Fortune Off Drug-Trial Participants</a>
<a href="https://www.bloomberg.com/features/2025-cancer-drug-markups/?srnd=undefined">One Generic Cancer Drug Costs $35. Or $134. Or $13,000.</a>

 Many Cancer Drugs Don’t Extend Life

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/96804cf7-0100-4d97-961f-b3b60173c0bd/transcript

The Philippines is no stranger to typhoons, but this year’s storms exposed something far uglier: a vast corruption scandal.

On today’s Big Take Asia Podcast, host K. Oanh Ha speaks to Bloomberg’s Andreo Calonzo and Rosalind Mathieson about how billions of dollars earmarked for flood control vanished and what the crisis means for the country’s political and economic stability.

The Philippines is no stranger to typhoons, but this year&rsquo;s storms exposed something far uglier: a vast corruption scandal.
On today&rsquo;s Big Take Asia Podcast, host K. Oanh Ha speaks to Bloomberg&rsquo;s Andreo Calonzo and Rosalind Mathieson about how billions of dollars earmarked for flood control vanished and what the crisis means for the country&rsquo;s political and economic stability.

The $2 Billion Flood Control Scandal Rocking the Philippines

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/63d0a7ba-593a-455d-9184-b3b5016234dd/transcript

We Got 18,000 of Jeffrey Epstein’s Emails

In 1 playlist(s)

Big Take

Social links

Follow podcast

Recent clips